tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PRQR is currently covered by 2 analysts with an average price target of $5.5. This is a potential upside of $6.63 (165.7%) from yesterday's end of day stock price of $2.07.
ProQR Therapeutics BV's activity chart (see below) currently has 37 price targets and 57 ratings on display. The stock rating distribution of PRQR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 21.67% with an average time for these price targets to be met of 98.93 days.
Highest price target for PRQR is $8, Lowest price target is $3, average price target is $5.5.
Most recent stock forecast was given by from CHARDAN CAPITAL on 26-Jun-2026. First documented stock forecast 26-Sep-2017.
Currently out of the existing stock ratings of PRQR, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-May-2024
$3
$1.47 (96.08%)
$4
Buy Since 30-Mar-2023
$8
$6.47 (422.88%)
$8
Buy Since 23-Dec-2022
$8
$6.47 (422.88%)
$8
Buy Since 31-Mar-2020
$12
$10.47 (684.31%)
$10
Hold Since 15-Feb-2022
$4
$2.47 (161.44%)
$2
What is PRQR (ProQR Therapeutics BV) average time for price targets to be met?
Which analyst has the current highest performing score on PRQR (ProQR Therapeutics BV) with a proven track record?
Which analyst has the most public recommendations on PRQR (ProQR Therapeutics BV)?
Which analyst is the currently most bullish on PRQR (ProQR Therapeutics BV)?
Which analyst is the currently most reserved on PRQR (ProQR Therapeutics BV)?
